For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Zura Bio Ltd (NASDAQ: ZURA) was $3.99 for the day, down -4.32% from the previous closing price of $4.17. In other words, the price has decreased by -$4.32 from its previous closing price. On the day, 1.95 million shares were traded. ZURA stock price reached its highest trading level at $4.28 during the session, while it also had its lowest trading level at $3.88.
Ratios:
Our analysis of ZURA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.40 and its Current Ratio is at 8.40. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Leerink Partners on November 04, 2024, initiated with a Outperform rating and assigned the stock a target price of $15.
On September 05, 2024, H.C. Wainwright started tracking the stock assigning a Neutral rating and target price of $5.
On May 03, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $26.Piper Sandler initiated its Overweight rating on May 03, 2024, with a $26 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 25 ’24 when Thiara Parvinder sold 1,001,633 shares for $2.73 per share. The transaction valued at 2,734,458 led to the insider holds 0 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZURA now has a Market Capitalization of 271125280 and an Enterprise Value of 118136048.
Stock Price History:
The Beta on a monthly basis for ZURA is 0.26, which has changed by 0.0025125742 over the last 52 weeks, in comparison to a change of 0.15927899 over the same period for the S&P500. Over the past 52 weeks, ZURA has reached a high of $5.07, while it has fallen to a 52-week low of $0.97. The 50-Day Moving Average of the stock is 84.93%, while the 200-Day Moving Average is calculated to be 144.94%.
Shares Statistics:
ZURA traded an average of 1.63M shares per day over the past three months and 7574890 shares per day over the past ten days. A total of 62.06M shares are outstanding, with a floating share count of 40.98M. Insiders hold about 36.97% of the company’s shares, while institutions hold 42.68% stake in the company. Shares short for ZURA as of 1757894400 were 458086 with a Short Ratio of 0.28, compared to 1755216000 on 544611. Therefore, it implies a Short% of Shares Outstanding of 458086 and a Short% of Float of 0.7799999999999999.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 7.0 analysts currently analyzing and rating the stock of Zura Bio Ltd (ZURA).The consensus estimate for the next quarter is -$0.18, with high estimates of -$0.13 and low estimates of -$0.21.
Analysts are recommending an EPS of between -$0.64 and -$0.78 for the fiscal current year, implying an average EPS of -$0.72. EPS for the following year is -$0.78, with 7.0 analysts recommending between -$0.7 and -$0.91.
